<p>根据最近向证券交易委员会的披露，Exchange Traded Concepts LLC 在第三季度将其在 CVS Health Corporation（纽约证券交易所代码：CVS - 免费报告）的持股增加了 86.7%。该基金在此期间购买了额外的 15,927 股后，持有 34,298 股该药房运营商的股票。根据其最近向证券交易委员会的备案，Exchange Traded Concepts LLC 在 CVS Health 的持股价值为 2,586,000 美元。</p>
<ul>
<li>CVS Health 因收入增长而获利，股息保持强劲</li>
</ul>
<p>其他一些机构投资者和对冲基金最近也买卖了该公司的股票。挪威银行在第二季度购买了 CVS Health 的新头寸，价值约为 1,358,698,000 美元。Invesco Ltd.在第二季度将其在 CVS Health 的持股增加了 15.3%。Invesco Ltd.现在拥有 23,532,479 股该药房运营商的股票，价值 1,623,270,000 美元，此前在上个季度购买了额外的 3,118,626 股。Robeco Institutional Asset Management B.V.在第二季度将其在 CVS Health 的头寸提升了 815.2%。Robeco Institutional Asset Management B.V.现在拥有 2,663,111 股该药房运营商的股票，价值 183,701,000 美元，此前在上个季度购买了额外的 2,372,121 股。Kingstone Capital Partners Texas LLC 在第二季度获得了 CVS Health 的新头寸，价值 155,185,000 美元。最后，Jennison Associates LLC 在第二季度将其在 CVS Health 的持股增加了 111.7%。Jennison Associates LLC 现在拥有 4,014,139 股该药房运营商的股票，价值 276,895,000 美元，此前在上个季度购买了额外的 2,117,798 股。目前，80.66% 的股票由机构投资者和对冲基金持有。</p>
<h2>分析师评级变动</h2>
<p>几位研究分析师最近对该股票进行了评估。Wolfe Research 将 CVS Health 的股票目标价从 85.00 美元上调至 100.00 美元，并在 12 月 8 日的研究报告中给予该公司 “跑赢大盘” 的评级。Weiss Ratings 在周一的报告中重申了对 CVS Health 的 “持有（c-）” 评级。摩根大通在 12 月 17 日的报告中将 CVS Health 的股票目标价从 93.00 美元上调至 101.00 美元，并给予该股票 “增持” 评级。Evercore ISI 在 10 月 30 日的报告中将 CVS Health 的目标价从 85.00 美元上调至 95.00 美元，并给予该公司 “跑赢大盘” 的评级。最后，Cantor Fitzgerald 在 12 月 10 日的研究报告中重申了对 CVS Health 的 “增持” 评级。有两位股票研究分析师给予该股票 “强烈买入” 评级，二十位给予 “买入” 评级，四位给予 “持有” 评级。根据 MarketBeat，该公司的平均评级为 “适度买入”，平均目标价为 94.67 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 05/12 - 05/16</li>
</ul>
<p><strong>查看我们对 CVS 的最新分析</strong></p>
<h2>CVS Health 股票表现</h2>
<p>CVS 股票在周五开盘价为 79.06 美元。CVS Health Corporation 的年低为 43.65 美元，年高为 85.15 美元。该公司的债务与股本比率为 0.83，速动比率为 0.63，流动比率为 0.83。该公司的 50 日移动平均价格为 78.97 美元，200 日移动平均价格为 72.79 美元。该公司的市值为 1003.5 亿美元，市盈率为 208.04，市盈增长比率为 0.78，贝塔值为 0.48。</p>
<ul>
<li>现在是购买 Novo Nordisk 股票的时机吗？</li>
</ul>
<p>CVS Health（纽约证券交易所代码：CVS - 获取免费报告）最近在 10 月 29 日宣布了其财报。该药房运营商报告本季度每股收益（EPS）为 1.60 美元，超出分析师共识预期的 1.36 美元，超出幅度为 0.24 美元。CVS Health 的股本回报率为 11.45%，净利润率为 0.12%。该公司本季度的收入为 1028.7 亿美元，而分析师预期为 988.5 亿美元。在去年同期，该公司每股收益为 1.09 美元。该公司的季度收入较去年同期增长了 7.8%。CVS Health 已将其 2025 财年的指导目标设定为每股收益 6.550-6.650 美元。整体而言，股票研究分析师预测 CVS Health Corporation 在当前年度将发布 5.89 美元的每股收益。</p>
<h2>CVS Health 简介</h2>
<p>（免费报告）</p>
<p>CVS Health Corporation 是一家多元化的医疗保健公司，运营着一个大型零售药房网络、药房福利管理服务和医疗解决方案。公司总部位于罗德岛州的伍恩索克特，追溯其根源至 20 世纪 60 年代初，已发展成为一个综合的处方药、非处方产品、临床服务和健康保险提供商。其运营模式结合了零售药房位置和店内诊所，以及更广泛的药房和健康计划能力。</p>
<p>主要业务活动包括 CVS 药房零售业务、MinuteClinic 步入式医疗诊所和提供扩展临床服务的 HealthHUB 地点。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票超过 CVS Health</li>
<li>在 1 月 1 日之前投入 1,000 美元到这只股票中 [不是 NVDA]</li>
<li>将你的 “死钱” 转变为每月 306 美元以上（从这个月开始）</li>
<li>华盛顿为战争做准备</li>
<li>奇怪的水晶金属表现优于硅达 100 倍</li>
<li>来自奇怪的新 “AI 燃料” 的 33,000% 繁荣</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元到 CVS Health 吗？</h2>
<p>在考虑 CVS Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 CVS Health 并不在名单上。</p>
<p>虽然 CVS Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

西维斯

<p>Exchange Traded Concepts LLC 在第三季度将其在 CVS Health Corporation 的持股增加了 86.7%，目前拥有 34,298 股，价值 259 万美元。其他机构投资者也调整了他们的持仓。分析师对 CVS Health 给予了 “适度买入” 的评级，目标价格为 94.67 美元。CVS 报告第三季度每股收益为 1.60 美元，超出预期，收入同比增长 7.8%。该公司运营着一个大型的零售药房和医疗服务网络</p>

<p>Exchange Traded Concepts LLC grew its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 86.7% in the third quarter, according to its most recent disclosure with the Securities &amp; Exchange Commission. The fund owned 34,298 shares of the pharmacy operator's stock after buying an additional 15,927 shares during the period. Exchange Traded Concepts LLC's holdings in CVS Health were worth $2,586,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p>
<div class="lb-trans"><p>根据最近向证券交易委员会的披露，Exchange Traded Concepts LLC 在第三季度将其在 CVS Health Corporation（纽约证券交易所代码：CVS - 免费报告）的持股增加了 86.7%。该基金在此期间购买了额外的 15,927 股后，持有 34,298 股该药房运营商的股票。根据其最近向证券交易委员会的备案，Exchange Traded Concepts LLC 在 CVS Health 的持股价值为 2,586,000 美元。</p>
</div><ul>
<li>CVS Health Gains as Revenue Grows, Dividend Remains Strong</li>
</ul>
<div class="lb-trans"><ul>
<li>CVS Health 因收入增长而获利，股息保持强劲</li>
</ul>
</div><p>A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Norges Bank purchased a new position in CVS Health in the 2nd quarter worth approximately $1,358,698,000. Invesco Ltd. increased its holdings in shares of CVS Health by 15.3% in the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator's stock valued at $1,623,270,000 after purchasing an additional 3,118,626 shares during the last quarter. Robeco Institutional Asset Management B.V. lifted its position in CVS Health by 815.2% during the second quarter. Robeco Institutional Asset Management B.V. now owns 2,663,111 shares of the pharmacy operator's stock worth $183,701,000 after buying an additional 2,372,121 shares in the last quarter. Kingstone Capital Partners Texas LLC acquired a new position in CVS Health during the second quarter worth $155,185,000. Finally, Jennison Associates LLC grew its holdings in CVS Health by 111.7% in the 2nd quarter. Jennison Associates LLC now owns 4,014,139 shares of the pharmacy operator's stock valued at $276,895,000 after buying an additional 2,117,798 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他一些机构投资者和对冲基金最近也买卖了该公司的股票。挪威银行在第二季度购买了 CVS Health 的新头寸，价值约为 1,358,698,000 美元。Invesco Ltd.在第二季度将其在 CVS Health 的持股增加了 15.3%。Invesco Ltd.现在拥有 23,532,479 股该药房运营商的股票，价值 1,623,270,000 美元，此前在上个季度购买了额外的 3,118,626 股。Robeco Institutional Asset Management B.V.在第二季度将其在 CVS Health 的头寸提升了 815.2%。Robeco Institutional Asset Management B.V.现在拥有 2,663,111 股该药房运营商的股票，价值 183,701,000 美元，此前在上个季度购买了额外的 2,372,121 股。Kingstone Capital Partners Texas LLC 在第二季度获得了 CVS Health 的新头寸，价值 155,185,000 美元。最后，Jennison Associates LLC 在第二季度将其在 CVS Health 的持股增加了 111.7%。Jennison Associates LLC 现在拥有 4,014,139 股该药房运营商的股票，价值 276,895,000 美元，此前在上个季度购买了额外的 2,117,798 股。目前，80.66% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>Several research analysts have recently weighed in on the stock. Wolfe Research boosted their price target on shares of CVS Health from $85.00 to $100.00 and gave the company an &#34;outperform&#34; rating in a research report on Monday, December 8th. Weiss Ratings reiterated a &#34;hold (c-)&#34; rating on shares of CVS Health in a report on Monday. JPMorgan Chase &amp; Co. raised their price target on shares of CVS Health from $93.00 to $101.00 and gave the stock an &#34;overweight&#34; rating in a report on Wednesday, December 17th. Evercore ISI upped their price objective on CVS Health from $85.00 to $95.00 and gave the company an &#34;outperform&#34; rating in a report on Thursday, October 30th. Finally, Cantor Fitzgerald reiterated an &#34;overweight&#34; rating on shares of CVS Health in a research report on Wednesday, December 10th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of &#34;Moderate Buy&#34; and an average target price of $94.67.</p>
<div class="lb-trans"><p>几位研究分析师最近对该股票进行了评估。Wolfe Research 将 CVS Health 的股票目标价从 85.00 美元上调至 100.00 美元，并在 12 月 8 日的研究报告中给予该公司 “跑赢大盘” 的评级。Weiss Ratings 在周一的报告中重申了对 CVS Health 的 “持有（c-）” 评级。摩根大通在 12 月 17 日的报告中将 CVS Health 的股票目标价从 93.00 美元上调至 101.00 美元，并给予该股票 “增持” 评级。Evercore ISI 在 10 月 30 日的报告中将 CVS Health 的目标价从 85.00 美元上调至 95.00 美元，并给予该公司 “跑赢大盘” 的评级。最后，Cantor Fitzgerald 在 12 月 10 日的研究报告中重申了对 CVS Health 的 “增持” 评级。有两位股票研究分析师给予该股票 “强烈买入” 评级，二十位给予 “买入” 评级，四位给予 “持有” 评级。根据 MarketBeat，该公司的平均评级为 “适度买入”，平均目标价为 94.67 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 05/12 - 05/16</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 05/12 - 05/16</li>
</ul>
</div><p><strong>Check Out Our Latest Analysis on CVS</strong></p>
<div class="lb-trans"><p><strong>查看我们对 CVS 的最新分析</strong></p>
</div><h2>CVS Health Stock Performance</h2>
<div class="lb-trans"><h2>CVS Health 股票表现</h2>
</div><p>Shares of CVS stock opened at $79.06 on Friday. CVS Health Corporation has a one year low of $43.65 and a one year high of $85.15. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. The firm's 50 day moving average price is $78.97 and its 200-day moving average price is $72.79. The firm has a market cap of $100.35 billion, a P/E ratio of 208.04, a P/E/G ratio of 0.78 and a beta of 0.48.</p>
<div class="lb-trans"><p>CVS 股票在周五开盘价为 79.06 美元。CVS Health Corporation 的年低为 43.65 美元，年高为 85.15 美元。该公司的债务与股本比率为 0.83，速动比率为 0.63，流动比率为 0.83。该公司的 50 日移动平均价格为 78.97 美元，200 日移动平均价格为 72.79 美元。该公司的市值为 1003.5 亿美元，市盈率为 208.04，市盈增长比率为 0.78，贝塔值为 0.48。</p>
</div><ul>
<li>Is It Time to Buy the Dip in Novo Nordisk Stock?</li>
</ul>
<div class="lb-trans"><ul>
<li>现在是购买 Novo Nordisk 股票的时机吗？</li>
</ul>
</div><p>CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The company had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. During the same quarter in the previous year, the company earned $1.09 earnings per share. The firm's quarterly revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities research analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.</p>
<div class="lb-trans"><p>CVS Health（纽约证券交易所代码：CVS - 获取免费报告）最近在 10 月 29 日宣布了其财报。该药房运营商报告本季度每股收益（EPS）为 1.60 美元，超出分析师共识预期的 1.36 美元，超出幅度为 0.24 美元。CVS Health 的股本回报率为 11.45%，净利润率为 0.12%。该公司本季度的收入为 1028.7 亿美元，而分析师预期为 988.5 亿美元。在去年同期，该公司每股收益为 1.09 美元。该公司的季度收入较去年同期增长了 7.8%。CVS Health 已将其 2025 财年的指导目标设定为每股收益 6.550-6.650 美元。整体而言，股票研究分析师预测 CVS Health Corporation 在当前年度将发布 5.89 美元的每股收益。</p>
</div><h2>CVS Health Profile</h2>
<div class="lb-trans"><h2>CVS Health 简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.</p>
<div class="lb-trans"><p>CVS Health Corporation 是一家多元化的医疗保健公司，运营着一个大型零售药房网络、药房福利管理服务和医疗解决方案。公司总部位于罗德岛州的伍恩索克特，追溯其根源至 20 世纪 60 年代初，已发展成为一个综合的处方药、非处方产品、临床服务和健康保险提供商。其运营模式结合了零售药房位置和店内诊所，以及更广泛的药房和健康计划能力。</p>
</div><p>Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.</p>
<div class="lb-trans"><p>主要业务活动包括 CVS 药房零售业务、MinuteClinic 步入式医疗诊所和提供扩展临床服务的 HealthHUB 地点。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than CVS Health</li>
<li>Put $1,000 into this stock by Jan 1 [Not NVDA]</li>
<li>Turn your &#34;dead money&#34; into $306+ monthly (starting this month)</li>
<li>Washington prepares for war</li>
<li>Strange Crystal Metal Outperforms Silicon Up to 100X</li>
<li>33,000% boom from weird new “AI Fuel?”</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 CVS Health</li>
<li>在 1 月 1 日之前投入 1,000 美元到这只股票中 [不是 NVDA]</li>
<li>将你的 “死钱” 转变为每月 306 美元以上（从这个月开始）</li>
<li>华盛顿为战争做准备</li>
<li>奇怪的水晶金属表现优于硅达 100 倍</li>
<li>来自奇怪的新 “AI 燃料” 的 33,000% 繁荣</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CVS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CVS Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元到 CVS Health 吗？</h2>
</div><p>Before you consider CVS Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 CVS Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 CVS Health 并不在名单上。</p>
</div><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CVS Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Exchange Traded Concepts LLC 增加了在西维斯健康公司 $CVS 的持仓